Achaogen

Achaogen company information, Employees & Contact Information

Explore related pages

Related company profiles:

About usIndustryBiotechnology ResearchCompany size1 employeeHeadquartersSouth San Francisco, CATypePublic CompanyFounded2004

Company Details

Employees
18
Founded
-
Address
South San Francisco, Ca 94080, Us
Phone
(650) 800-3636
Email
in****@****gen.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
South San Francisco, CA
Looking for a particular Achaogen employee's phone or email?

Achaogen Questions

News

Achaogen bankruptcy raises worry over antibiotic pipeline - CIDRAP

Achaogen bankruptcy raises worry over antibiotic pipeline CIDRAP

Achaogen Provides Data to SPARK, Pew’s Platform for Antibiotic Discovery Research - The Pew Charitable Trusts

Achaogen Provides Data to SPARK, Pew’s Platform for Antibiotic Discovery Research The Pew Charitable Trusts

Novel insights from financial analysis of the failure to commercialise plazomicin: Implications for the antibiotic investment ecosystem | Humanities and Social Sciences Communications - Nature

Novel insights from financial analysis of the failure to commercialise plazomicin: Implications for the antibiotic investment ecosystem | Humanities and Social Sciences Communications Nature

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae - The New England Journal of Medicine

Plazomicin for Infections Caused by Carbapenem-Resistant Enterobacteriaceae The New England Journal of Medicine

Achaogen files for bankruptcy protection, seeks asset sale - BioPharma Dive

Achaogen files for bankruptcy protection, seeks asset sale BioPharma Dive

The Antibiotics Business Is Broken—But There's a Fix - WIRED

The Antibiotics Business Is Broken—But There's a Fix WIRED

Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseases - PNAS

Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseases PNAS

FDA Panel Votes on Plazomicin for Complicated UTI, Bloodstream Infections - Medical Professionals Reference

FDA Panel Votes on Plazomicin for Complicated UTI, Bloodstream Infections Medical Professionals Reference

ZEMDRITM (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI) - GlobeNewswire

ZEMDRITM (plazomicin) Approved by FDA for the Treatment of Adults with Complicated Urinary Tract Infections (cUTI) GlobeNewswire

Antibiotic developer Achaogen files for bankruptcy - Chemical & Engineering News

Antibiotic developer Achaogen files for bankruptcy Chemical & Engineering News

Achaogen To Present At Needham Healthcare Conference ; Webcast At 10:40 AM ET - RTTNews

Achaogen To Present At Needham Healthcare Conference ; Webcast At 10:40 AM ET RTTNews

It's a good news, bad news FDA approval for Achaogen's powerful antibiotic Zemdri - Fierce Pharma

It's a good news, bad news FDA approval for Achaogen's powerful antibiotic Zemdri Fierce Pharma

Achaogen slides after ‘yes and no’ adcomm verdict on plazomicin - Fierce Biotech

Achaogen slides after ‘yes and no’ adcomm verdict on plazomicin Fierce Biotech

Achaogen Claims Over Lost Ch. 11 Sales Can Go Forward - Law360

Achaogen Claims Over Lost Ch. 11 Sales Can Go Forward Law360

A decade of incentives to promote antibiotic development and still no viable route to commercial success - BioWorld MedTech

A decade of incentives to promote antibiotic development and still no viable route to commercial success BioWorld MedTech

Commentary: How to Cure the Antibiotic Industry’s Profitability Infection - Fortune

Commentary: How to Cure the Antibiotic Industry’s Profitability Infection Fortune

Achaogen wields ax on R&D, C-suite as antibiotic launch gets underway - Fierce Biotech

Achaogen wields ax on R&D, C-suite as antibiotic launch gets underway Fierce Biotech

Achaogen gets a yes and a no for antibiotic Zemdri - BioPharma Dive

Achaogen gets a yes and a no for antibiotic Zemdri BioPharma Dive

Achaogen to share data from discontinued antibiotic program - CIDRAP

Achaogen to share data from discontinued antibiotic program CIDRAP

FDA Hands Achaogen Split Approval and Rejection for Plazomicin - BioSpace

FDA Hands Achaogen Split Approval and Rejection for Plazomicin BioSpace

Meet the Chief Scientific Officers - Pharma Voice

Meet the Chief Scientific Officers Pharma Voice

Achaogen shares soar on antibiotic trial success - The Pharma Letter

Achaogen shares soar on antibiotic trial success The Pharma Letter

How this big South S.F. tower landed its 1st biotech tenant - The Business Journals

How this big South S.F. tower landed its 1st biotech tenant The Business Journals

Melinta files for bankruptcy in another dark day for antibiotics - Fierce Biotech

Melinta files for bankruptcy in another dark day for antibiotics Fierce Biotech

AMRI to Provide Discovery Services to Achaogen for its Biodefense Contract - Genetic Engineering and Biotechnology News

AMRI to Provide Discovery Services to Achaogen for its Biodefense Contract Genetic Engineering and Biotechnology News

Change at every level needed to crack drug resistance - SciDev.Net

Change at every level needed to crack drug resistance SciDev.Net

Top Achaogen Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant